Skip to content
Open access

Design, Computational Study, Synthesis, Characterization and Anti-diabetic Evaluation of Novel N-Substituted Thiazolidinedione Derivatives

Oct 2026 · Asian Journal of Chemistry · Vol 38, pp. 2809-2827 · 0 citations · 21 references

TL;DR

This study identifies PB-TZD3 as a promising lead compound and highlights the significance of N-substitution in optimizing thiazolidinedione derivatives for improved antidiabetic activity.

Abstract

In the present study, a series of novel N-substituted 2,4-thiazolidinedione derivatives (PB-TZD1–PB-TZD14) were rationally designed, synthesized and evaluated for their antidiabetic potential. The synthesized compounds were characterized by FT-IR, 1H NMR, 13C NMR and mass spectrometry. Molecular docking revealed favourable interactions of the synthesized derivatives with key residues of the PPAR-γ receptor, particularly Cys285. In vitro glucose uptake studies revealed that PB-TZD1 (36.00%), PB-TZD3 (34.30%) and PB-TZD6 (33.53%) exhibited significantly higher activity compared to the standard drug pioglitazone (24.77%). Among these, PB-TZD3 exhibited the most pronounced glucose-lowering effect in in vivo antidiabetic studies using a high-fat diet STZ-induced rat model. Adipocyte differentiation studies showed that PB-TZD3 significantly enhanced adipogenesis at higher concentrations, consistent with PPAR-γ activation. In silico ADME and toxicity predictions suggested favourable drug-like properties; however, these findings are preliminary and require further experimental validation. The structure–activity relationship analysis indicated that electronic, steric and hydrophobic factors play a crucial role in modulating biological activity. This study identifies PB-TZD3 as a promising lead compound and highlights the significance of N-substitution in optimizing thiazolidinedione derivatives for improved antidiabetic activity.

Read PDF

Similar papers

Open access Oct 2026

Synthesis, molecular docking, and in vitro cytotoxicity of novel N-(α-cyanocinnamoyl)hydralazine derivatives

Background and purpose: Treatment resistance in many cancers is a major concern, requiring the development of new anticancer agents to overcome it. Hence, in the present study, a novel series of (2E)-2-cyano-3-substituted phenyl-N'-(phthalazin-1-yl)prop-2-enehydrazide derivatives (4a-h) were synthesized and tested agai...

R. Galla, Vidya Rani Murthi, Vanitha Madhuri Tadepalli et al. · 0 citations
Open access Oct 2026

Design, synthesis, biological evaluation and molecular docking studies of some new quinoxaline azetidinone analogues

Quinoxaline and azetidinone (β-lactam) derivatives are well-known heterocyclic scaffolds possesses diverse biological activities, including antimicrobial, antioxidant, and antidiabetic properties. Owing to the growing need for novel and effective therapeutic agents to combat drug resistance and various metabolic disord...

Paras Jain, Nitin Kumar, R. Marwaha et al. · 0 citations
Oct 2026

Design, Synthesis, and In Vitro Antioxidant Evaluation of Novel Oxazole Derivatives

Background: Oxazole derivatives represent an important class of heterocyclic compounds with diverse biological activities, including antioxidant potential. The present study aimed to synthesize and characterize a series of 2,4-disubstituted oxazole derivatives and evaluate their in vitro radical-scavenging activity.Met...

S. Joshi · 0 citations
Open access Sep 2026

Design, synthesis, and preliminary anticancer evaluation of diphenylpropan-1-one derivatives: in vitro, in vivo and in silico studies

A series of diphenylpropan-1-one (DPP) derivatives (4a–4i), rationally designed around a chalcone framework and synthesized via a three-step reaction sequence demonstrated encouraging preliminary anticancer potential and may serve as promising lead molecules for future investigations.

A. Najmi, M. S. Alam, W. Ahsan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.